ROCHE (PHILIPPINESS) INC

Featured products of Roche

Actemra

Actemra soln for infusion (conc) 200 mg/10 mL

tocilizumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Actemra soln for infusion (conc) 400 mg/20 mL

tocilizumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Actemra soln for infusion (conc) 80 mg/4 mL

tocilizumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Actemra soln for inj 162 mg/0.9 mL

tocilizumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Alecensa

Alecensa cap 150 mg

alectinib

Packing/Price

224's56's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.

Avastin

Avastin infusion 100 mg/4 mL

bevacizumab

Packing/Price

(vial) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Avastin infusion 400 mg/16 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Evrysdi

Evrysdi powd for oral soln 750 mcg/mL

risdiplam

Packing/Price

(strawberry flavor) 100 mL x 1's

MIMS Class

Other Drugs Acting on Musculo-Skeletal System

ATC Classification

M09AX10 - risdiplam : Belongs to the class of other drugs for disorders of the musculo-skeletal system.

Hemlibra

Hemlibra soln for inj 105 mg/0.7 mL

emicizumab

Packing/Price

3 mL x 1's

MIMS Class

Haemostatics

ATC Classification

B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.

Hemlibra soln for inj 150 mg/mL

emicizumab

Packing/Price

3 mL x 1's

MIMS Class

Haemostatics

ATC Classification

B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.

Hemlibra soln for inj 30 mg/mL

emicizumab

Packing/Price

3 mL x 1's

MIMS Class

Haemostatics

ATC Classification

B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.

Hemlibra soln for inj 60 mg/0.4 mL

emicizumab

Packing/Price

3 mL x 1's

MIMS Class

Haemostatics

ATC Classification

B02BX06 - emicizumab : Belongs to the class of other systemic hemostatics. Used in the treatment of hemorrhage.

Herceptin

Herceptin lyophilized powd for infusion (conc) 150 mg

trastuzumab

Packing/Price

15 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Herceptin soln for inj 600 mg/5 mL

trastuzumab

Packing/Price

5 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Mabthera

Mabthera soln for infusion (conc) 100 mg/10 mL

rituximab

Packing/Price

10 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

Mabthera soln for infusion (conc) 500 mg/50 mL

rituximab

Packing/Price

50 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

Perjeta

Perjeta soln for infusion 30 mg/mL

pertuzumab

Packing/Price

(single-use vial) 14 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD02 - pertuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Phesgo

Phesgo 1,200 mg/600 mg soln for inj

pertuzumab, trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XY02 - pertuzumab and trastuzumab : Belongs to the class of combinations of antineoplastic agents. Used in the treatment of cancer.

Phesgo 600 mg/600 mg soln for inj

pertuzumab, trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XY02 - pertuzumab and trastuzumab : Belongs to the class of combinations of antineoplastic agents. Used in the treatment of cancer.

Polivy

Polivy powd for conc for soln for infusion 140 mg

polatuzumab vedotin

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX14 - polatuzumab vedotin : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Tecentriq

Tecentriq conc for soln for infusion 60 mg/mL

atezolizumab

Packing/Price

20 mL x 1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Vabysmo

Vabysmo soln for intravitreal inj 120 mg/mL

faricimab

Packing/Price

(single dose + transfer filter needle) 2 mL x 1's

MIMS Class

Other Eye Preparations

ATC Classification

S01LA09 - faricimab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Xofluza

Xofluza FC tab 20 mg

baloxavir marboxil

Packing/Price

4's2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Xofluza FC tab 40 mg

baloxavir marboxil

Packing/Price

2's1's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Distributor for Patheon

Kadcyla

Kadcyla powd for infusion 100 mg

trastuzumab emtansine

Packing/Price

15 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kadcyla powd for infusion 160 mg

trastuzumab emtansine

Packing/Price

20 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Distributed by Globo Asiatico

Herceptin

Herceptin lyophilized powd for infusion (conc) 150 mg

trastuzumab

Packing/Price

15 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Herceptin soln for inj 600 mg/5 mL

trastuzumab

Packing/Price

5 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Distributed by Zuellig

Actemra

Actemra soln for infusion (conc) 200 mg/10 mL

tocilizumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Actemra soln for infusion (conc) 400 mg/20 mL

tocilizumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Actemra soln for infusion (conc) 80 mg/4 mL

tocilizumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Actemra soln for inj 162 mg/0.9 mL

tocilizumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AC07 - tocilizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Avastin

Avastin infusion 100 mg/4 mL

bevacizumab

Packing/Price

(vial) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Avastin infusion 400 mg/16 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Mabthera

Mabthera soln for infusion (conc) 100 mg/10 mL

rituximab

Packing/Price

10 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

Mabthera soln for infusion (conc) 500 mg/50 mL

rituximab

Packing/Price

50 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FA01 - rituximab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.

Perjeta

Perjeta soln for infusion 30 mg/mL

pertuzumab

Packing/Price

(single-use vial) 14 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD02 - pertuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Marketer for Roche Diagnostics

Gazyva

Gazyva soln for infusion conc 1000 mg/40 mL

obinutuzumab

Packing/Price

50 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FA03 - obinutuzumab : Belongs to the class of CD20 (Clusters of Differentiation 20) inhibitors. Used in the treatment of cancer.